To Evaluate Efficacy and Safety of TT-00420 (Tinengotinib) as Monotherapy and Combination Therapy in Patients With Advanced Solid Tumors
Clinical trial NCT05253053 · COMPLETED
Trial details
- NCT number
- NCT05253053
- Sponsor
- TransThera Sciences (Nanjing), Inc.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-04-13
- Primary completion
- 2024-08-31
- Enrollment
- 84
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.